ACOX1：酰基辅酶A氧化酶1；ADH5：酒精脱氢酶5（III类），χ多肽；ADIPOQ：脂联素，C1Q和胶原结构域蛋白；ATG：自噬相关；BECN1：beclin 1；CRTC2：CREB调节转录激活物2；ER：内质网；F2RL1：F2R类胰凝乳酶受体1；FA：脂肪酸；FOXO1：Forkhead盒O1；GLP1R：胰高血糖素样肽1受体；GRK2：G蛋白偶联受体激酶2；GTPase：鸟苷三磷酸酶；HFD：高脂饮食；HSCs：肝星状细胞；HTRA2：HtrA丝氨酸蛋白酶2；IRGM：免疫相关GTP酶M；KD：沉默；KDM6B：赖氨酸去甲基化酶6B；KO：敲除；LAMP2：溶酶体相关膜蛋白2；LAP：LC3相关吞噬作用；LDs：脂滴；Li KO：肝特异性敲除；LSECs：肝窦内皮细胞；MAP1LC3/LC3：微管相关蛋白1轻链3；MAP3K5：有丝分裂活化蛋白激酶激酶激酶5；MED1：介导体复合物亚单位1；MTOR：雷帕霉素酸酶机械靶蛋白激酶；MTORC1：雷帕霉素酸酶蛋白激酶复合物1；NAFLD：非酒精性脂肪肝病；NASH：非酒精性脂肪性肝炎；NFE2L2：NFE2样bZIP转录因子2；NOS3：一氧化氮合酶3；NR1H3：核受体亚家族1群H成员3；OA：油酸；OE：过量表达；OSBPL8：类固醇与氧化的结合蛋白8；PA：棕榈酸；RUBCNL：与自噬增强相关的抑制剂；PLIN2：固醇密度脂蛋白2；PLIN3：固醇密度脂蛋白3；PPARA：过氧化物酶体增殖激活受体α；PRKAA2/AMPK：蛋白激酶D激活催化亚基α2；RAB：RAS家族肿瘤基因成员；RPTOR：雷帕霉素酸酶复合物1相关蛋白；SCD：硬脂酰辅酶A脱饱和酶；SIRT1：Sir2般1；SIRT3：Sir2般3；SNARE：可溶性N-乙酰硫酰亚胺敏感因子连接蛋白受体；SQSTM1/p62：包裹体1；SREBF1：甾醇调节元件结构域结合转录因子1；SREBF2：甾醇调节元件结构域结合转录因子2；STING1：干扰素应答cGAMP相互作用物1激活剂；STX17：syntaxin 17；TAGs：三酸甘油酯；TFEB：转录因子EB；TP53/p53：肿瘤蛋白p53；ULK1：未51类自噬活化激酶1；VMP1：液泡膜蛋白1。

ACOX1: acyl-CoA oxidase 1; ADH5: alcohol dehydrogenase 5 (class III), chi polypeptide; ADIPOQ: adiponectin, C1Q and collagen domain containing; ATG: autophagy related; BECN1: beclin 1; CRTC2: CREB regulated transcription coactivator 2; ER: endoplasmic reticulum; F2RL1: F2R like trypsin receptor 1; FA: fatty acid; FOXO1: forkhead box O1; GLP1R: glucagon like peptide 1 receptor; GRK2: G protein-coupled receptor kinase 2; GTPase: guanosine triphosphatase; HFD: high-fat diet; HSCs: hepatic stellate cells; HTRA2: HtrA serine peptidase 2; IRGM: immunity related GTPase M; KD: knockdown; KDM6B: lysine demethylase 6B; KO: knockout; LAMP2: lysosomal associated membrane protein 2; LAP: LC3-associated phagocytosis; LDs: lipid droplets; Li KO: liver-specific knockout; LSECs: liver sinusoidal endothelial cells; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAP3K5: mitogen-activated protein kinase kinase kinase 5; MED1: mediator complex subunit 1; MTOR: mechanistic target of rapamycin kinase; MTORC1: mechanistic target of rapamycin complex 1; NAFLD: non-alcoholic fatty liver disease; NASH: non-alcoholic steatohepatitis; NFE2L2: NFE2 like bZIP transcription factor 2; NOS3: nitric oxide synthase 3; NR1H3: nuclear receptor subfamily 1 group H member 3; OA: oleic acid; OE: overexpression; OSBPL8: oxysterol binding protein like 8; PA: palmitic acid; RUBCNL: rubicon like autophagy enhancer; PLIN2: perilipin 2; PLIN3: perilipin 3; PPARA: peroxisome proliferator activated receptor alpha; PRKAA2/AMPK: protein kinase AMP-activated catalytic subunit alpha 2; RAB: member RAS oncogene family; RPTOR: regulatory associated protein of MTOR complex 1; SCD: stearoyl-CoA desaturase; SIRT1: sirtuin 1; SIRT3: sirtuin 3; SNARE: soluble N-ethylmaleimide-sensitive factor attachment protein receptor; SQSTM1/p62: sequestosome 1; SREBF1: sterol regulatory element binding transcription factor 1;SREBF2: sterol regulatory element binding transcription factor 2; STING1: stimulator of interferon response cGAMP interactor 1; STX17: syntaxin 17; TAGs: triacylglycerols; TFEB: transcription factor EB; TP53/p53: tumor protein p53; ULK1: unc-51 like autophagy activating kinase 1; VMP1: vacuole membrane protein 1.